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Abstract
Novel hypotheses suggest that antidepressants, such as the selective serotonin reuptake inhibitor ﬂuoxetine,
induce neuronal structural plasticity, resembling that of the juvenile brain, although the underlying mechanisms
of this reopening of the critical periods still remain unclear. However, recent studies suggest that inhibitory
networks play an important role in this structural plasticity induced by ﬂuoxetine. For this reason we have
analysed the effects of a chronic ﬂuoxetine treatment in the hippocampus and medial prefrontal cortex
(mPFC) of transgenic mice displaying eGFP labelled interneurons. We have found an increase in the expression
of molecules related to critical period plasticity, such as the polysialylated form of the neural cell adhesion
molecule (PSA-NCAM), GAD67/65 and synaptophysin, as well as a reduction in the number of parvalbumin
expressing interneurons surrounded by perineuronal nets. We have also described a trend towards decrease
in the perisomatic inhibitory puncta on pyramidal neurons in the mPFC and an increase in the density of inhibi-
tory puncta on eGFP interneurons. Finally, we have found that chronic ﬂuoxetine treatment affects the structure
of interneurons in the mPFC, increasing their dendritic spine density. The present study provides evidence
indicating that ﬂuoxetine promotes structural changes in the inhibitory neurons of the adult cerebral cortex,
probably through alterations in plasticity-related molecules of neurons or the extracellular matrix surrounding
them, which are present in interneurons and are known to be crucial for the development of the critical periods
of plasticity in the juvenile brain.
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Introduction
Neuronal plasticity is required for the adaptation of the
brain to face a changing external environment. Several
lines of evidence during the last decade have suggested
that antidepressants may act by promoting this plasticity
(Duman et al., 2000; Castrén, 2005). The antidepressant
ﬂuoxetine, a selective serotonin reuptake inhibitor, pro-
motes different kinds of plasticity in the adult CNS, in-
cluding increased hippocampal neurogenesis (Malberg
et al., 2000), LTP induction (Rubio et al., 2013) or remodel-
ling in the structure of pyramidal neurons (Hajszan et al.,
2005; Guirado et al., 2009). However, to date most of the
research on the effects of antidepressants has been fo-
cused on excitatory neural networks, leaving their
action on inhibitory neurons almost unexplored (Chen
et al., 2011).
Recent research has promoted the development of a
new perspective on our understanding of the mode of ac-
tion of antidepressants: The structural plasticity induced
by antidepressants and particularly ﬂuoxetine, resembles
that naturally occurring during the critical periods of de-
velopment. Therefore, ﬂuoxetine may act by promoting a
‘dematuration’ in certain regions of the adult brain, such
as the limbic system (Kobayashi et al., 2010). Moreover,
research on the visual cortex has, in fact, demonstrated
that the plasticity induced by ﬂuoxetine is similar to
that observed during critical periods, when the neuronal
wiring of this cortical region is ﬁnally established
(Maya-Vetencourt et al., 2008).
Cell adhesion molecules and several components of
the extracellular matrix have been shown to be critical
for structural plasticity in the CNS (Sandi, 2004;
Dityatev et al., 2010; Tiraboschi et al., 2013). In this re-
gard, the polysialylated form of the neural cell
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adhesion molecule (PSA-NCAM) and the perineuronal
nets (PNNs) are interesting candidates to mediate these
changes. These molecules have been both demonstrated
to play a key role in synaptogenesis and neurite remodel-
ling (Rutishauser, 2008; Howell and Gottschall, 2012).
While PSA-NCAM is widely considered a marker of
developing neurons, which expression decreases as devel-
opment progresses (Probstmeier et al., 1994; Kurosawa
et al., 1997; Oltmann-Norden et al., 2008), PNNs are
considered indicators of neuronal maturation and, con-
sequently, the number of neurons expressing these
specialized regions of the extracellular matrix increases
with age (McRae et al., 2007; Nowicka et al., 2009).
Fluoxetine treatment induces a similar type of juvenile
plasticity in the adult amygdala, allowing the erasure
of fear memories. This reopening of the critical period
was correlated with an increase in the expression of
PSA-NCAM and with a reduction of the ratio of PNNs ex-
pressing parvalbumin (Karpova et al., 2011). In agree-
ment with this plasticity-promoting role, the enzymatic
removal of these molecules has an impact on the critical
period plasticity. Removal of PSA-NCAM accelerates
the maturation of the visual cortex and the closure of
the critical period (Di Cristo et al., 2007), while removal
of PNNs delays this maturation and maintains open the
critical period for a longer time (Pizzorusso et al., 2002).
However, little is known of the effect of this antide-
pressant in the hippocampus or the mPFC, two regions
critically involved in the aetiopathology of major
depression.
It is interesting to note that both PSA-NCAM and
PNNs are found in subsets of interneurons in the
adult cerebral cortex. PNNs mainly appear surrounding
parvalbumin expressing interneurons (Brückner et al.,
1994), and PSA-NCAM is expressed mainly by calbin-
din expressing interneurons, although it is also found
in a lower proportion in the somata of other inter-
neuronal populations and in parvalbumin expressing
perisomatic puncta surrounding pyramidal neurons
(Gómez-Climent et al., 2010; Castillo-Gómez et al.,
2011). This suggests that interneurons may play a key
role in the structural plasticity induced by the antide-
pressant ﬂuoxetine. In fact, a recent report has demon-
strated that chronic treatment with ﬂuoxetine alters
GABA release from synapses formed by fast-spiking cells,
resulting in the disruption of γ oscillations (Méndez
et al., 2012).
Thus, in order to better understand how ﬂuoxetine
inﬂuences the structural plasticity and the connectivity
of interneurons in the mPFC and the hippocampus, we
have analysed the effects of ﬂuoxetine on: (i) the ratio of
PNNs surrounding PV interneurons, (ii) the expression
of PSA-NCAM and synaptic molecules related to inhibi-
tory neurotransmission in the neuropil, (iii) the periso-
matic innervation of pyramidal and inhibitory neurons,
and (iv) the structure of interneurons in these two cortical
regions.
Method
Animal treatments
Twelve male GIN (GFP-expressing inhibitory neurons,
Tg(GadGFP)45704Swn) (Oliva et al., 2000), three-month-
old mice were used in this study. They were maintained
in standard conditions of light (12 h cycles) and temp-
erature, with no limit in the access to food or water. All
animal experimentation was conducted in accordance
with the Directive 2010/63/EU of the European
Parliament and of the Council of 22 September 2010 on
the protection of animals used for scientiﬁc purposes and
was approved by the Committee on Bioethics of the
Universitat de València. Every effort was made to mini-
mize the number of animals used and their suffering.
Mice received daily i.p. injections either with the antide-
pressantﬂuoxetine (n=6, 20mg/kg), orwith saline solution
(n=6), over 14 days (once daily at 10.00 am). Previous
studies have shown that this dose and length of treatment
produces increases in the expression of plasticity-related
molecules in the regions analysed (Umathe et al., 2011;
Yu et al., 2011; Méndez et al., 2012). The day after these
treatments, mice were perfused transcardially under
deep chloral hydrate anaesthesia (4%, 0.01ml/g), ﬁrst
with saline and thenwith 4%paraformaldehyde in sodium
phosphate buffer (PB 0.1 M, pH 7.4). After perfusion, the
brains were extracted and stored in PB 0.1 M and sodium
azide 0.05%. The two hemispheres were separated, then
one hemisphere was cut into 50 μm thick sections, while
the other was cut into 100 μm thick sections, both with
a vibratome (Leica VT 1000E, Leica). The sections were
collected in six and three subseries, respectively, and stored
at 4 °C in PB 0.1 M and sodium azide 0.05% until used.
Immunohistochemistry
Tissue was processed free-ﬂoating for ﬂuorescence
immunohistochemistry. Sections were washed in phos-
phate buffered saline (PBS), then slices were incubated
in 10% normal donkey serum (NDS) (Abcys SA), 0.2%
Triton-X100 (Sigma) in PBS for 1 h. Sections were then
incubated for 48 h at 4 °C with different primary antibody
cocktails diluted in PBS – 0.2% Triton-X100 (see Table 1).
After washing, sections were incubated for 2 h at room
temperature with different secondary antibody cocktails
also diluted in PBS – 0.2% Triton-X100 (see Table 1).
Finally, sections were washed in PB 0.1 M, mounted on
slides and coverslipped using ﬂuorescence mounting
medium (Dako).
In the present study we used only commercial anti-
bodies whose speciﬁcity was proved by the provider.
Additionally, when the antigen used for generating the
primary antibody was available, we ﬁrst co-incubated
them in accordance with the immunohistochemical pro-
tocol in order to block the binding of these antibodies
to the tissue antigens. In the cases of anti-GAD6 and
anti-CAMKII antibodies no access was available to the
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antigens used for their generation. However, these
antibodies are included in the JCN AntibodyDatabase:
http://onlinelibrary.wiley.com/journal/10.1002/%28ISSN%
2910969861/homepage/jcn_antibody_database.htm. The
antibodies on this list have been described and character-
ized adequately according to the strict guidelines of the
journal, including appropriate controls. The primary anti-
bodies against VGLUT1 and PV were pre-adsorbed with
the peptides used for their generation by their commercial
source: AG208 (Millipore) and SySy 195-0P (synaptic
systems), respectively. The primary antibody against
SYN was pre-adsorbed with a synaptophysin recombi-
nant protein (H00006855-P01, Novus). The antibody
against PSA-NCAM was co-incubated with alpha-2,8-
sialic acid (Colominic acid, Sigma). The performance of
the immunohistochemical procedure using these blocked
antibodies resulted in a total absence of immunostaining.
The Wisteria ﬂoribunda lectin was pre-adbsorbed with
N-Acetyl-D-galactosamine (Sigma, A2795). The perform-
ance of the histochemical procedure using this blocked
lectin also resulted in a total absence of staining.
Analysis of immunoreactive puncta in single
confocal planes
We analysed the density of puncta expressing different
markers in single confocal planes (Olympus FV10i) of dif-
ferent regions of the mouse brain, as previously described
(Guirado et al., 2012). We imaged an area located within
layer V of the medial prefrontal cortex (mPFC). In this
layer reside the pyramidal neurons that provide the
main output projection of this region, which project ex-
tensively to the striatum (Lévesque and Parent, 1998).
We analysed the different regions of the mPFC in two dif-
ferent sections: the prelimbic (PrL) and the infralimbic
cortices (IL; in sections corresponding to Bregma +1.78mm)
and the ventral and dorsal cingulate cortices (Cg1 and
Cg2 respectively; Bregma +1.1mm). Different regions
and strata of the hippocampus were also analysed
(Bregma −2.18mm): the hilus and the molecular layer
of the dentate gyrus, the stratum lacunosum-moleculare,
radiatum and oriens of CA1 and the stratum lucidum
of CA3. Confocal z-stacks of the superﬁcial layers of
the slices, for optimal penetration levels for antibody
recognition were selected.
On these planes, three small areas of the neuropil
(505 μm2) were selected for analysis, in order to avoid
blood vessels and cell somata. Images were processed
using ImageJ software. The background was subtracted
with a rolling value of 50, converted to 8-bit deep images
and binarized using a determined threshold value. This
value depended on the marker and the area analysed
and was kept the same for all images with the same mar-
ker and area. The images were then processed with a blur
ﬁlter to reduce noise and separate closely apposed
puncta. Finally, the number of the resulting dots per
region was counted (Fig. S1).
Analysis of the density of perisomatic puncta
We analysed the density of puncta surrounding the cell
somata of pyramidal neurons and interneurons using
a similar methodology to that described above. In the
mPFC, between 20 and 30 pyramidal neurons were
imaged per animal in three different sections and similar
numbers where analysed in the CA1 region of the hippo-
campus. However, only between 10 and 15 interneurons
were counted per region (also both in the mPFC and
the hippocampus), since their density was more limited.
Images were processed using ImageJ. The proﬁle of the
plasmatic membrane of every soma was delimited manu-
ally, and then the selection was enlarged 1 μm in order to
cover the area surrounding the somata. The selected area
was processed for binarization as described above.
Analysis of spine density
To study the spine density of interneurons we selected
individual dendrites from eGFP-expressing neurons in
deep layers of the mPFC and in the CA1 region of the hip-
pocampus. Stacks of confocal images were obtained with
a 63×objective and an additional 3.5 digital zoom. The
spines were counted in three dendritic fragments (around
60 μm each) expanding until 180 μm from the soma. The
length of every dendritic fragment was measured and
the data was expressed in density of spines per 10 μm.
Table 1. List of primary and secondary antibodies used in the
study
Dilution Company
Primary antibodies
Monoclonal mouse anti-PSA-NCAM 1:2000 Millipore
Polyclonal guinea pig antivesicular
glutamate transporter 1
1:2000 Millipore
Polyclonal rabbit anti-synaptophysin 1:1000 Millipore
Monoclonal mouse anti-glutamic acid
decarboxylase 65/67
1:500 DSHB
Polyclonal guinea pig
anti-parvalbumin
1:2000 Synaptic
Systems
Polyclonal chicken anti-GFP 1:1000 Millipore
WFA lectin biotin-conjugated 1:200 Sigma
Monocolonal mouse anti-CaMKII 1:500 Abcam
Secondary antibodies
Goat anti-mouse A555-conjugated 1:400 Invitrogen
Donkey anti-rabbit A555-conjugated 1:400 Invitrogen
Goat anti-guinea pig A647-conjugated 1:400 Invitrogen
Donkey anti-chickenA488-conjugated 1:400 Invitrogen
Streptavidin A647-conjugated 1:400 Invitrogen
Donkey anti-mouse
DL649-conjugated
1:400 Jackson
Donkey anti-mouse A488-conjugated 1:400 Invitrogen
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Estimation of number of cells
We also estimated the number of cells expressing par-
valbumin (PV) or surrounded by perineuronal nets
(PNN) as previously described (Nacher et al., 2002b). In
brief, we analysed sections selected by a 1:6 fractionator
sampling covering the whole rostral to caudal extension
of the mPFC and the hippocampus CA1.
Statistics
We have used two-way ANOVAs to analyse the data
whenever we had to consider more than one factor, as
in the analysis of the density of immunoreactive puncta
in different subregions or the density of spines at different
distances from the soma. For comparing two means with
only one factor, we used unpaired t-tests, as in the study
of the perisomatic innervation and the total number
of cells expressing PV, surrounded by PNNs, PV/PNNs
positive cells, or the ratio of PNNs surrounding PV
immunoreactive neurons. For all statistics the number
of animals in each group was considered as the ‘n’.
Results
Chronic ﬂuoxetine treatment alters the expression
of plasticity-related molecules in interneurons of the
mPFC and the hippocampus
We found that animals treated with ﬂuoxetine displayed
a non-signiﬁcant trend towards a decreased number of
PV-expressing interneurons in the CA1 region of the
hippocampus (p=0.098; Fig. 1). In addition, the number
of PV interneurons expressing PNNs was signiﬁcantly
reduced (p=0.014). Moreover, another parameter typi-
cally measured to evaluate the maturation degree of a cere-
bral region (Karpova et al., 2011) was also affected—the
ratio of neurons surrounded by PNNs that co-expressed
PV—was signiﬁcantly reduced (p=0.016). In the mPFC
of mice treated with ﬂuoxetine we found a non-signiﬁcant
trend towards a decrease in the number of neurons
surrounded by PNNs (p=0.094; Fig. 2) and a signiﬁcant
reduction in the number of PV interneurons expressing
PNN (p=0.042). However, the ratio mentioned above
was not affected in this region.
We found that after chronic ﬂuoxetine treatment
there are signiﬁcant increases in the density of PSA-
NCAM-expressing puncta in the strata lacunosum-
moleculare (p=0.040; Fig. 3), radiatum (p=0.048) and
oriens (p=0.002). Similar increases were found in the den-
sity of synaptophysin (SYN)-expressing puncta in the
strata lucidum (p=0.045), moleculare (p=0.008), oriens
(p=0.027) and radiatum (p=0.016). We also found a sign-
iﬁcant increase (p=0.016) in the density of glutamic acid
decarboxylase 67/65 (GAD6)-expressing puncta in the
hilus. However, we did not ﬁnd any change in the den-
sity of the vesicular glutamate transporter 1 (VGluT1)-
expressing puncta in any of the areas analysed. In the
mPFC we only found a non-signiﬁcant trend towards
an increase in the density of neuropil-expressing
PSA-NCAM (p=0.060; Fig. 3) and SYN (p=0.073) in the
Cg2 region, in animals chronically treated with ﬂuoxe-
tine. Furthermore, we did not ﬁnd any changes in the
expression of GAD6 or of VGluT1 in any region of the
mPFC.
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Fig. 1. Expression of PV and PNNs, after chronic ﬂuoxetine treatment, in the hippocampus. (a & d): Single confocal planes showing
the expression of PV and the presence of PNNs in the CA1 region of the hippocampus of mice treated either with saline (a) or
ﬂuoxetine (d). (b & e): Higher magniﬁcation microphotographs showing differences in the number of neurons co-expressing both
markers. (c & f): Graphs showing the changes in cells expressing each of the markers, expressing both markers and the ratio of total
PNNs surrounding PV-expressing neurons (Unpaired T-test, p-values: #<0.1, *<0.05). Scale bar 377 μm in A and D, 41 μm in (b) and
(e). PNNs: perineuronal nets; PV: parvalbumin.
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Chronic ﬂuoxetine treatment increases the number of
inhibitory perisomatic puncta on interneurons but not
on pyramidal neurons
We analysed the density of PV positive puncta sur-
rounding the somata of pyramidal neurons and its
co-localization with SYN (Fig. 4). In the hippocampus
we did not observe any change in the density of PV- or
SYN- expressing puncta or in the density of PV puncta
expressing SYN after ﬂuoxetine treatment. However, in
the mPFC we found a non-signiﬁcant trend towards a de-
crease in the density of perisomatic-PV-puncta-expressing
SYN (p=0.080; Fig. 4).
We observed an increase in the density of GAD6-
expressing puncta surrounding the somata of inter-
neurons expressing eGFP in the CA1 region of the
hippocampus of animals treated with ﬂuoxetine (p=0.015;
Fig. 4). Although there were no changes in the density
of puncta expressing SYN surrounding the somata of
these interneurons, we also found an increase in the
density of perisomatic-GAD6-puncta-expressing SYN
(p=0.028; Fig. 4). However, in the mPFC we found
no changes in the density of perisomatic puncta on
interneurons.
Chronic ﬂuoxetine treatment increases the dendritic
spine density in interneurons of the mPFC
We described recently that this subpopulation of
eGFP interneurons display spines on their dendrites
(Gómez-Climent et al., 2010), whose dynamics are
inﬂuenced by PSA-NCAM expression (Guirado et al.,
2013). As some of these interneurons co-express
PSA-NCAM,we studied both subpopulations: eGFP inter-
neurons expressing PSA-NCAM and those lacking this
molecule. We compared the dendritic spine density of
interneurons expressing PSA-NCAM in animals treated
with ﬂuoxetine and those injected with saline and we
found that, in our paradigm, ﬂuoxetine does not affect
the dendritic spine density of these interneurons in the
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Fig. 2. Expression of PV and PNN after chronic ﬂuoxetine treatment in the mPFC. (a & d): Single confocal planes showing the
expression of PV and the presence of PNNs in the mPFC of mice treated either with saline (a) or ﬂuoxetine (d). (b & e): Higher
magniﬁcation microphotographs showing differences in the number of neurons co-expressing both markers. (c & f): Graphs
showing the changes in cells expressing each of the markers, both markers and the ratio of total PNNs surrounding PV-expressing
neurons (Unpaired T-test, p-values: #<0.1, *<0.05). Scale bar 286 μm in (a) and (d), 41 μm in (b) and (e). PNNs: perineuronal nets;
PV: parvalbumin.
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Fig. 3. Expression of molecules related to neuronal plasticity in the different strata of the hippocampus (a–d) and the mPFC (e–h).
(a): Graphs showing the density of puncta-expressing PSA-NCAM. (b): Graphs showing the density of puncta-expressing SYN.
(c): Graphs showing the density of puncta-expressing GAD6. (d): Graphs showing the density of puncta-expressing VGluT1
(One-way ANOVA, p-values: *<0.05, **<0.01). (e): Graphs showing the density of puncta-expressing PSA-NCAM. (f): Graphs
showing the density of puncta-expressing SYN. (g): Graphs showing the density of puncta-expressing GAD6. (h): Graphs showing
the density of puncta-expressing VGluT1. (One-way ANOVA, p-values: #<0.1). GAD6: Glutamic acid decarboxylase 65/67; SYN:
synaptophysin; VGluT1: vesicular glutamate transporter 1.
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Fig. 4. (a & b): Effects of chronic ﬂuoxetine treatment on the perisomatic innervation of pyramidal neurons. Single confocal
planes of the CA1 stratum pyramidale of the hippocampus showing CAMKIIα-expressing pyramidal neuron somata (green) and
perisomatic-puncta-expressing PV (blue) or SYN (red) in saline (a) and ﬂuoxetine treated (b) mice. (a1–a2 & b1–b2): Single confocal
planes showing PV- (a1, b1), and SYN- (a2, b2) expressing puncta surrounding the somata of a pyramidal neuron of saline (a series)
and ﬂuoxetine treated (b series) mice. (c & d): Histograms showing the perisomatic density of the puncta-expressing the different
markers surrounding pyramidal neurons in the hippocampus and the mPFC. (Unpaired T-test, p-values: #<0.1). (e & f): Effects of
chronic ﬂuoxetine treatment on the perisomatic innervation of interneurons. Single confocal planes of eGFP-expressing interneurons
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hippocampus. Similarly, we did not ﬁnd changes when
comparing eGFP-expressing interneurons lacking PSA-
NCAM, after ﬂuoxetine treatment. However, we repli-
cated our previous results, conﬁrming that interneurons
expressing PSA-NCAM have a reduced dendritic spine
density compared with interneurons lacking this molecule
(Fig. S2).
However, in the mPFC, where eGFP-expressing inter-
neurons always lack PSA-NCAM expression, we found
that animals treated with ﬂuoxetine had a signiﬁcant
increase in dendritic spine density in these interneurons
(p=0.005). When analysing the different segments, we
found that these changes were especially more intense
in the distal segment of the dendrites (p=0.008; Fig. 5).
Discussion
In the current study, we described the effects of chronic
treatment with ﬂuoxetine on different parameters affect-
ing inhibitory networks in the hippocampus and the
mPFC. This antidepressant increases the number of in-
hibitory perisomatic puncta on interneurons, but not on
pyramidal neurons, and increases the density of dendritic
spines in interneurons of the mPFC. Fluoxetine induces
these changes in inhibitory networks and through puta-
tive mechanisms alters the expression of the polysialylated
form of the neural cell adhesion molecule (PSA-NCAM)
and the number of perineuronal nets (PNNs). Both mole-
cules (PSA-NCAM and PNNs) play an important role in
the plasticity associated with the development and closure
of critical period plasticity, are mainly associated with
interneurons in the adult cerebral cortex and are con-
sidered markers of neuronal development and of neuronal
maturation, respectively.
We have found that the chronic ﬂuoxetine treatment
used in our study does not induce signiﬁcant alterations
in the density of perisomatic puncta on the mPFC pyrami-
dal neurons, although there was a trend for a decrease in
the number of puncta co-expressing PV and SYN. These
results are in contrast to those of a recent report, which
has found that chronic treatment with ﬂuoxetine alters
GABA release from synapses formed by hippocampal
fast-spiking cells, resulting in the disruption of γ oscilla-
tions (Méndez et al., 2012). It is possible that the lack of
signiﬁcant differences in the density of perisomatic
puncta found in our study may be due to the fact that, de-
spite the fact that the doses used were the same, our mice
were treated with ﬂuoxetine for two weeks only while the
rats in Méndez et al. (2012) study received the treatment
for three weeks.
We found that, similar to pyramidal neurons, the
somata of interneurons expressing eGFP are also sur-
rounded by puncta expressing the inhibitory marker
GAD6 and that chronic ﬂuoxetine treatment induces a
dramatic increase in the density of these perisomatic
puncta in the hippocampus, but not in the mPFC.
Although the co-localization with synaptophysin indi-
cates that these perisomatic inhibitory puncta may corre-
spond to active synapses, it is still complicated to discuss
the functional implications of their increase via ﬂuoxetine.
It would be necessary to perform new experiments
including electron microscopy to clarify which sub-
population/s are affected by this putative increase in
perisomatic inhibition.
Our study shows for the ﬁrst time that chronic treat-
ment with ﬂuoxetine alters the structure of interneurons.
Previous studies have demonstrated that ﬂuoxetine treat-
ment increases the dendritic spine density in pyramidal
neurons of the hippocampus (Hajszan et al., 2005) and
the somatosensory cortex (Guirado et al., 2009), but
there is no information on its effect on the mPFC. We
found that ﬂuoxetine induces an increase in the density
of dendritic spines in eGFP-labelled interneurons in the
mPFC, but not in those of the hippocampal CA1 region.
A recent report by our laboratory has revealed that
these spines receive mainly excitatory synapses
(Guirado et al., 2013). In the mPFC of the strain of mice
used in the present study, eGFP-labelled interneurons
correspond to Martinotti cells (Gilabert-Juan et al.,
2013), which innervate the distal portion of the dendritic
arbour of pyramidal neurons (Markram et al., 2004). If the
new synapses that these interneurons receive on their
spines are functional, then they may enhance the excit-
atory input that these interneurons receive and, in turn,
enhance the inhibition produced on mPFC pyramidal
neurons. This would be in accordance with previous
reports describing increased expression of molecules
involved in inhibitory neurotransmission in rats chroni-
cally treated with ﬂuoxetine (Varea et al., 2007a;
Guirado et al., 2012; Tiraboschi et al., 2013). Since a pre-
vious report has described decreased cortical inhibition
in the visual cortex of rats chronically treated with ﬂuox-
etine (Maya-Vetencourt et al., 2008), it is possible that
the changes in the structure of interneurons and the
located in the CA1 region of the hippocampus showing eGFP in their somata (green) and perisomatic-puncta-expressing GAD6
(blue) or SYN (red) in saline (e) and ﬂuoxetine treated ( f ) mice. (e1–e2 & f1–f2): Single confocal planes showing SYN- (e1, f1) and
GAD6- (e2, f2) expressing puncta surrounding the somata of an eGFP-expressing interneuron of saline (e series) and ﬂuoxetine
treated ( f series) mice. (g & h): Histograms showing the perisomatic density of the puncta-expressing the different markers
surrounding eGFP-expressing interneurons in the hippocampus and the mPFC. (Unpaired T-test, p-values: *<0.05). Scale bar 5 μm
in (a) and (b), 2.5 μm in (a1–a2 and b1–b2), 20 μm in (e) and ( f ), 6.4 μm in (e1–e2 and f1–f2). CAMKIIα: anti-a subunit of the
Ca2 +/calmodulin dependent protein kinase II; GAD6: glutamic acid decarboxylase 65/67; PV: parvalbumin; SYN: synaptophysin.
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expression of molecules related to inhibitory neuro-
transmission correspond to a compensatory mechanism.
We also conﬁrm that this increase in the expression
of molecules related to cortical inhibition in the hippo-
campus and mPFC is correlated with signiﬁcant increases
in SYN and PSA-NCAM (Varea et al., 2007a, b; Guirado
et al., 2012) suggesting the formation of new inhibitory
synapses after ﬂuoxetine treatment. In fact, previous
studies from our laboratory have demonstrated that
PSA-NCAM is exclusively expressed by a subpopulation
of interneurons in the mPFC of both humans and mice
(Varea et al., 2005, 2007a). In the hippocampus
PSA-NCAM is found in a subpopulation of interneurons
(Nacher et al., 2002a; Gómez-Climent et al., 2010) but is
also intensely expressed in the axons of a subset of gran-
ule neurons (Seki and Arai, 1999). In the rest of hippo-
campal structures, PSA-NCAM expression is mainly
restricted to inhibitory elements (Gómez-Climent
et al., 2010). Interestingly, interneurons expressing
PSA-NCAM showed more reduced density of synaptic
inputs, dendritic arborisation and dendritic spine density
(corroborated in the present study, Fig. S2) compared
to interneurons lacking this molecule (Gómez-Climent
et al., 2010). However, its long-term speciﬁc ablation
decreases the spine density of interneurons (Guirado
et al., 2013). Indicating that an altered expression of
PSA-NCAM, as that found after ﬂuoxetine treatments
(Varea et al., 2007a; Karpova et al., 2011; Guirado et al.,
2012), might inﬂuence the structure of interneurons.
However, the present results suggest that PSA-NCAM
may not be directly implicated in the structural changes
we have described in the mPFC interneurons. The
GAD67- EGFP expressing interneurons in which the
structural features have been analysed normally do not
show PSA-NCAM expression in their somata, neurites
or in the puncta located in their projection ﬁelds in layers
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Fig. 5. Effects of ﬂuoxetine on the spine density of interneurons in the mPFC. (a & b): Reconstruction of focal planes showing
a dendrite carrying spines of an eGFP-expressing interneuron of animals treated with saline (a) or ﬂuoxetine (b). (a1 & b1): Higher
magniﬁcation images showing the difference in dendritic spine density observed between both groups. (c): Histograms showing
the dendritic spine density per 10 μm at three different segments of 60 μm each, considering their distance to the cell soma. (d):
Graph showing the total spine density after ﬂuoxetine treatment. (Two-way ANOVA; p-values *<0.05). Scale bar 8 μm in (a) and (b),
2.1 μm in (a1 and b1).
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I and II (Gilabert-Juan et al., 2013). Moreover, we did not
ﬁnd an increase in the expression of PSA-NCAM in the
mPFC as we expected (only a non-signiﬁcant trend).
This contrast in the ability to up-regulate PSA-NCAM ex-
pression after ﬂuoxetine treatment between hippocampal
and mPFC interneurons may be due to differences in the
phenotype (differential expression of calcium binding
proteins and neuropeptides) of these subsets of inhibitory
neurons. In fact, in control animals the interneurons that
express PSA-NCAM in basal conditions belong to differ-
ent phenotypic subpopulations in these two regions
(Gómez-Climent et al., 2010).
Finally, we found signiﬁcant reductions in the number
of PV-expressing interneurons surrounded by PNN, both
in the mPFC and the CA1 region of the hippocampus.
This is in accordance with a previous report, which
found similar reductions in the CA1 region and the baso-
lateral amygdala (Karpova et al., 2011). The presence of
PNNs is considered a marker of the maturation degree
of PV-expressing interneurons and, in fact, the appear-
ance of PNNs during late development has been used
as an indication of critical period closure (Hensch, 2005;
Bavelier et al., 2010; Yamada and Jinno, 2013), in which
PV-expressing interneurons and their afferent connec-
tions play a critical role. In fact, removal of PNNs pro-
duces a dematuration of the axonal boutons innervating
the pyramidal neurons, which results in a reopening of
the critical periods (McRae et al., 2007; Nowicka et al.,
2009). These results suggest that this same type of plas-
ticity might be occurring in the mPFC and hippocampus
after ﬂuoxetine treatment. However, as mentioned above,
we only found a non-signiﬁcant trend for a decrease in
the density of perisomatic puncta expressing PV and
SYN in the mPFC and no changes in the hippocampus,
suggesting that, despite its effects on PNNs, the duration
of this chronic ﬂuoxetine treatment (two weeks) is not
sufﬁcient to induce changes in the perisomatic inner-
vation of pyramidal neurons.
Summarizing, the effects of antidepressants, affecting
the structure and connectivity of certain interneuronal
subpopulations, probably through the alteration in the
speciﬁc expression of PSA-NCAM in interneurons and
the relationship of these inhibitory cells with PNNs,
may induce a window of plasticity resembling that of
the critical periods. These changes may contribute in
reverting the alterations of GABAergic neurotransmission
in major depression patients (Sanacora et al., 2002, 2004)
and, consequently, new therapeutic approaches directed
to the modulation of PNNs or PSA-NCAM may consti-
tute promising strategies to the development of innova-
tive antidepressant drugs.
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